Janus Henderson Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RRAM
Janus Henderson Group's HAE Position: Q1 2026 in Review
Janus Henderson Group reduced its Haemonetics (HAE) stake by 0.3% in Q1 2026, selling an estimated $36.2K and leaving 186,163 shares worth $10.5M. The position accounts for 0.01% of the portfolio, ranked #751.
Janus Henderson Group first reported a position in HAE in Q2 2021 and has held it in 19 quarters since. The position peaked at $85M in Q3 2021. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Janus Henderson Group held 186,163 shares of Haemonetics worth $10.5M as of Q1 2026.
- Janus Henderson Group sold 556 Haemonetics shares in Q1 2026, an estimated $36.2K.
- Haemonetics made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #751 holding.
- Janus Henderson Group first reported a position in Haemonetics in Q2 2021 and has held it in 19 quarters since.
- Janus Henderson Group's Haemonetics position peaked at $85M in Q3 2021.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.